GlassScriptPhysician profile
Jody M Kaban
NPI 1518044825
$13,815.04
in general payments reported to CMS, 2019-2025
13 companies · $1,410 in 2025
The $1,410 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2020: $143 · 2021: $9.96 · 2022: $639 · 2023: $8,992 · 2024: $2,088 · 2025: $1,410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,000 · Travel and Lodging: $4,738 · Food and Beverage: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,000.00 |
| Travel and Lodging | $4,737.94 |
| Food and Beverage | $751.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,380.54 | 2022-2024 | Davinci Xi, Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $1,390.79 | 2020-2025 | Pectus Bar Bending Forceps, Standard, Ribfix Titan |
| Livanova USA, INC. | $515.13 | 2019 | |
| Ambu INC. | $125.00 | 2023 | |
| Heron Therapeutics, INC. | $123.88 | 2025 | Zynrelef |
| Atricure, INC. | $104.63 | 2024 | |
| Baxter Healthcare | $45.01 | 2023 | Tisseel |
| Davol INC. | $42.61 | 2023 | Phasix Mesh |
| Vertex Pharmaceuticals Incorporated | $23.76 | 2025 | |
| Kls-Martin L.P. | $20.48 | 2024 | |
| Avanos Medical | $18.87 | 2019 | |
| Solventum Corporation | $14.38 | 2025 | Prevena |
| Cardiovascular Systems INC. | $9.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jody Kaban listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.